Newport Coast, CA, August 2, 2023 (Business Wire) -- VivoSense, Inc. ("VivoSense") is delighted to introduce Colin Bower as their new Chief Executive Officer and a valued addition to their Board of Directors. As he takes the helm, Bower brings a wealth of experience and vision to drive the next stage of VivoSense's development.
Read full article here.
Palo Alto, CA, May 2, 2024 (Globe Newswire) -- BridgeBio Pharma, Inc. (Nasdaq: BBIO) recently completed a $200M private financing round for its former subsidiary, TheRas, Inc. d/b/a BridgeBio Oncolo
San Diego, CA, May 2, 2024 (QuidelOrtho) -- Brian J. Blaser has been appointed as the new President and CEO of QuidelOrtho. Most recently overseeing Abbott's global diagnostics organization, he brin
Watertown, MA, May 2, 2024 (finance.yahoo.com) -- Novartis is acquiring Mariana Oncology, a biotech firm specializing in targeted radiation medicines, for $1 billion. Mariana could receive up to $75
